News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,488 Results
Type
Article (1923)
Company Profile (3)
Press Release (67562)
Section
Business (21463)
Career Advice (9)
Deals (4552)
Drug Development (8163)
FDA (1805)
Job Trends (802)
News (37018)
Policy (3560)
Tag
Academia (93)
Alliances (8125)
Alzheimer's disease (121)
Antibody-drug conjugate (ADC) (10)
Approvals (1827)
Artificial intelligence (12)
Bankruptcy (8)
Best Places to Work (587)
Biosimilars (18)
Breast cancer (15)
Cancer (171)
Career advice (9)
Cell therapy (20)
Clinical research (6960)
Collaboration (72)
COVID-19 (186)
C-suite (11)
Data (148)
Diabetes (12)
Diagnostics (595)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7533)
Events (6924)
Executive appointments (41)
FDA (1912)
Funding (46)
Gene therapy (14)
GLP-1 (41)
Government (233)
Healthcare (1075)
Infectious disease (191)
Inflammatory bowel disease (17)
Intellectual property (9)
IPO (1620)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (949)
Liver cancer (15)
Lung cancer (27)
Lymphoma (10)
Manufacturing (25)
Medical device (1114)
Medtech (1115)
Mergers & acquisitions (3005)
Metabolic disorders (34)
Neuroscience (155)
NextGen: Class of 2025 (221)
Non-profit (61)
Northern California (116)
Obesity (15)
Ovarian cancer (8)
Parkinson's disease (12)
Patents (14)
People (4944)
Phase I (1891)
Phase II (2911)
Phase III (2646)
Pipeline (70)
Postmarket research (241)
Preclinical (654)
Radiopharmaceuticals (22)
Rare diseases (22)
Real estate (598)
Regulatory (2563)
Research institute (93)
Schizophrenia (6)
Series A (11)
Southern California (118)
Startups (421)
United States (1059)
Vaccines (20)
Date
Today (20)
Last 7 days (70)
Last 30 days (212)
Last 365 days (3151)
2025 (396)
2024 (3254)
2023 (3815)
2022 (7015)
2021 (6374)
2020 (5874)
2019 (3863)
2018 (3010)
2017 (3561)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Arizona (7)
Asia (21269)
Australia (2426)
California (273)
Canada (197)
China (128)
Connecticut (12)
Europe (12359)
Florida (16)
Illinois (16)
India (8)
Japan (58)
Maryland (68)
Massachusetts (191)
Minnesota (26)
New Jersey (157)
New York (122)
North Carolina (53)
Northern California (116)
Pennsylvania (41)
South America (105)
Southern California (118)
Texas (20)
Utah (10)
Virginia (17)
Washington State (9)
69,488 Results for "biosight ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, announced the closing of its merger with Biosight, Ltd., pursuant to which Ayala acquired Biosight.
October 19, 2023
·
6 min read
Deals
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
Ayala Pharmaceuticals, Inc. and Biosight Ltd. today announced they have entered into a definitive merger agreement pursuant to which Ayala will combine with Biosight in an all-stock transaction.
July 27, 2023
·
11 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
February 27, 2025
·
2 min read
Press Releases
Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations
February 26, 2025
·
1 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Drug Development
Biosight Launches a Phase 1/2 Clinical Trial of Aspacytarabine in Combination with Venetoclax for First-Line AML Induction Therapy, Followed by Aspacytarabine Consolidation
Biosight Ltd today announced enrollment of a first patient to a phase 1/2 clinical trial designed to evaluate the safety and efficacy of its lead asset aspacytarabine (BST-236) in combination with the BCL2 inhibitor venetoclax for induction therapy of newly-diagnosed Acute Myeloid Leukemia (AML), followed by aspacytarabine single-agent consolidation therapy.
November 22, 2022
·
3 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
1 of 6,949
Next
